KSE - Delayed Quote KRW

JW Lifescience Corporation (234080.KS)

11,900.00
-50.00
(-0.42%)
At close: 3:30:30 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
NameTitlePayExercisedYear Born
Sungnam Cha CEO & Director -- -- --
Jeong Yeol Noh Executive Director & Head of HP Research Center -- -- --
Na Sook Hee Executive Director -- -- --

JW Lifescience Corporation

28, Hanjin 1-gil
Songak-eup
Dangjin-si, 31720
South Korea
82 4 1351 7600 https://www.jw-lifescience.co.kr
Sector: 
Healthcare

Description

JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.

Corporate Governance

JW Lifescience Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

December 27, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers